Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 31.51% vs 37.66% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 55.06% vs 109.34% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 0.01% vs 18.43% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 61.64% vs 286.10% in Mar 2025
Compare Profit and Loss Results of Neochem Bio
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
110.00
285.00
-175.00
-61.40%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
110.00
285.00
-175.00
-61.40%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-2.00
3.00
150.00%
Raw Materials Consumed
73.00
260.00
-187.00
-71.92%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
8.00
4.00
4.00
100.00%
Operating Expenses
2.00
1.00
1.00
100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
4.00
-3.00
-75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
90.00
275.00
-185.00
-67.27%
Operating Profit (PBDIT) excl Other Income
19.00
9.00
10.00
111.11%
Other Income
2.00
5.00
-3.00
-60.00%
Operating Profit (PBDIT)
22.00
14.00
8.00
57.14%
Interest
3.00
3.00
0.00
0.00%
Profit before Depriciation and Tax
19.00
11.00
8.00
72.73%
Depreciation
1.00
4.00
-3.00
-75.00%
Profit Before Taxation & Exceptional Items
17.00
7.00
10.00
142.86%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
20.00
-3.00
-15.00%
Provision for Tax
5.00
5.00
0.00
0.00%
Profit After Tax
12.00
14.00
-2.00
-14.29%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
11.00
91.00
-80.00
-87.91%
Profit Available for appropriations
23.00
106.00
-83.00
-78.30%
Appropriations
23.00
106.00
-83.00
-78.30%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.71
0.09
8.62
9,577.78%
Profit And Loss - Net Sales
Net Sales 110.70 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 31.51% vs 37.66% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.85 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 55.06% vs 109.34% in Mar 2025
Profit And Loss - Interest
Interest 3.51 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.01% vs 18.43% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 12.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 61.64% vs 286.10% in Mar 2025
Footer loading
